As most studies examining the role of GDF5 in cardiac repair were in the context of myocardial infarction, future functional studies to determine the exact role that downregulation of GDF5 plays in the context of global transcriptional toxicity (e.g. assessed via RNA-seq in patient-derived cells) are warranted. The gene discussed is GDF5; the disease is myocardial infarction.